Prevalence of colorectal cancer and breast cancer screening according to history of diabetes in 2010-2019

J Med Screen. 2023 Sep;30(3):156-158. doi: 10.1177/09691413231175724. Epub 2023 May 31.

Abstract

As cancer is overtaking cardiovascular disease as the leading cause of death among diabetics, improved cancer prevention efforts are needed for individuals with diabetes. In this research letter, we used data from the US National Health Interview Survey to examine the use of screening for two major diabetes-related cancers, colorectal cancer, and breast cancer, in individuals with and without diabetes. We found that individuals with diabetes had slightly higher use of colorectal cancer screening and similar use of breast cancer screening compared to those without diabetes in the US. Besides, despite the increasing use of colorectal cancer and breast cancer screening over the past 10 years, screening uptake remains suboptimal. We believe that these findings provide important data to inform policymaking and cancer prevention efforts.

Keywords: Cancer prevention; breast cancer; cancer screening; colorectal cancer; diabetes.

Publication types

  • Letter

MeSH terms

  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / epidemiology
  • Colorectal Neoplasms* / diagnosis
  • Colorectal Neoplasms* / epidemiology
  • Diabetes Mellitus* / diagnosis
  • Diabetes Mellitus* / epidemiology
  • Early Detection of Cancer
  • Female
  • Humans
  • Mass Screening
  • Prevalence